Share

May 14, 2013; 80 (20) Article

Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden

Chengxuan Qiu, Eva von Strauss, Lars Bäckman, Bengt Winblad, Laura Fratiglioni
First published April 17, 2013, DOI: https://doi.org/10.1212/WNL.0b013e318292a2f9
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
527

Share

Article Information

vol. 80 no. 20 1888-1894
DOI: 
https://doi.org/10.1212/WNL.0b013e318292a2f9
PubMed: 
23596063
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received October 4, 2012
  • Accepted in final form January 22, 2013
  • First Published April 17, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Chengxuan Qiu, PhD,
    2. Eva von Strauss, PhD,
    3. Lars Bäckman, PhD,
    4. Bengt Winblad, MD, PhD and
    5. Laura Fratiglioni, MD, PhD
  1. Chengxuan Qiu, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Alzheimer Disease, Associated Editor, 2010- 2013.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. The Swedish Research Council, Project no. K2008-69X-20821-01-3, Years 2008-2012 and K2012-99X-21967-01-3, Years 2012-2015. (3) The Swedish Council for Working Life and Social Research, Grant No. 2007-1172, Years 2008-2012.

    Research Support, Academic Entities:

    1. Karolinska Institutet, Stockholm, Sweden

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Eva von Strauss, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Lars Bäckman, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Aging, Neuropsychology, and Cognition

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Swedish Research Council Swedish Council for Working Life and Social Research Swedish Brain Power Alexander von Humboldt Foundation af Jochnick Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Bengt Winblad, MD, PhD and
    5. Scientific Advisory Boards:

    1. Pharmaceutical companies having anti-dementia drugs.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel costs covered and receiving honoraria for scientific presentations at conferences and scientific advisory board meetings (SAB).

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. See above, SAB

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Swedish Research Council (3 yrs). Knut&Alice Wallenberg foundation (5yrs).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Laura Fratiglioni, MD, PhD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From Aging Research Center (C.Q., E.v.S., L.B., B.W., L.F.), Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet–Stockholm University; The Red Cross Hospital and the Red Cross University College in Sweden (E.v.S.); Stockholm Gerontology Research Center (L.B., L.F.); and KI-Alzheimer’s Disease Research Center (B.W.), Department of NVS, Karolinska Institutet, Stockholm, Sweden.
  1. Correspondence to Dr. Qiu: chengxuan.qiu{at}ki.se
View Full Text

Article usage

Article usage: April 2013 to April 2021

AbstractFullPdfSource
Apr 2013744030Highwire
May 201315684187Highwire
Jun 20133111319Highwire
Jul 20132811521Highwire
Aug 2013163910Highwire
Sep 20131221117Highwire
Oct 201313699Highwire
Nov 20131261511Highwire
Dec 2013157811Highwire
Jan 201412989Highwire
Feb 201411568Highwire
Mar 20149977Highwire
Apr 2014901213Highwire
May 201410545Highwire
Jun 20146457Highwire
Jul 20147733Highwire
Aug 20144076Highwire
Sep 20143796Highwire
Oct 20145776Highwire
Nov 2014401711Highwire
Dec 20146043Highwire
Jan 20154734Highwire
Feb 20153672Highwire
Mar 2015561715Highwire
Apr 20154933Highwire
May 20154087Highwire
Jun 20154522Highwire
Jul 20155655Highwire
Aug 20157542Highwire
Sep 20157044Highwire
Oct 20153846Highwire
Nov 20154236Highwire
Dec 20152211Highwire
Jan 20162956Highwire
Feb 20164120Highwire
Mar 20164655Highwire
Apr 20165101Highwire
May 20163011Highwire
Jun 20166732Highwire
Jul 20163433Highwire
Aug 20164238Highwire
Sep 20164344Highwire
Oct 20166810Highwire
Nov 20164611Highwire
Dec 20167355Highwire
Jan 20176952Highwire
Feb 20176301Highwire
Mar 20174932Highwire
Apr 20173986Highwire
May 20173901Highwire
Jun 20175462Highwire
Jul 20172823Highwire
Aug 20175533Highwire
Sep 20173243Highwire
Oct 20174432Highwire
Nov 20175112Highwire
Dec 20176455Highwire
Jan 20187944Highwire
Feb 20185682Highwire
Mar 20185694Highwire
Apr 20185911Highwire
May 20185233Highwire
Jun 20188372Highwire
Jul 20185032Highwire
Aug 201813521Highwire
Sep 201810424Highwire
Oct 201810145Highwire
Nov 20187814Highwire
Dec 20189722Highwire
Jan 20195100Highwire
Feb 20196834Highwire
Mar 20199356Highwire
Apr 20192822Highwire
May 20198723Highwire
Jun 20195611Highwire
Jul 20193521Highwire
Aug 20196824Highwire
Sep 20198823Highwire
Oct 20199033Highwire
Nov 20195823Highwire
Dec 20194621Highwire
Jan 20204132Highwire
Feb 20204200Highwire
Mar 20204134Highwire
Apr 20202823Highwire
May 20203844Highwire
Jun 20203100Highwire
Jul 20205014Highwire
Aug 20205501Highwire
Sep 202081104Highwire
Oct 20206983Highwire
Nov 20208152Highwire
Dec 20205801Highwire
Jan 20213632Highwire
Feb 20216343Highwire
Mar 20215634Highwire
Apr 20219331Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me